Cost Effectiveness and Delivery Study for Future HIV Vaccines
Saladin Osmanov
WHO-UNAIDS HIV Vaccine Initiative, World Health Organization, Geneva, Switzerland
Research teams from five countries, Brazil, China, Kenya, Peru and Thailand, have initiated a policy-maker survey on vaccine delivery, cost studies for future HIV vaccination programmes, and associated simulation modeling exercises analyzing the relative cost-effectiveness of potential for HIV vaccination strategies.  The survey assesses challenges and opportunities for future country-level HIV vaccination strategies, providing data on the vaccine characteristics (e.g. vaccine efficacies for susceptibility, infectiousness and disease progression) and vaccination programme strategies to be considered in the cost-effectiveness modeling analyses.  The study will provide decision-makers with modeling data on vaccination policy considerations that will assist in developing country-level capacities for future HIV vaccine policy adoption and effective delivery systems, and will help delineate the long-term financial requirements for sustainable HIV vaccination programmes. The WHO-UNAIDS HIV Vaccine Initiative and the collaborating researchers welcome comments or questions from policy makers, health professionals and other stakeholders in the public and private sectors about this effort to help advance policy and capacity related to future potential HIV vaccines.  
AIDS Care ปี 2548, ปีที่: 19 ฉบับที่ หน้า w1-w6
AIDS, cost effectiveness, Vaccine, ACCESS, Capacity, Delivery, HIV, Immunization strategies, Policy